joint with HIV Pathogenesis
Organizer(s): Ruth M. Ruprecht, Genoveffa Franchini and Susan W. BarnettDate: March 27 - April 02, 2006
Location: Keystone Resort, Keystone, CO, USA
The Vaccine Symposium will focus on basic aspects of antigen presentation, with a special attention to the role of MHC class II and the generation of antibodies. Over the last few years, MHC class I-restricted cytotoxicity lymphocytes (CTL) have been in the limelight. However, vaccine strategies aimed at generating CTL responses have only been partially protective and have not provided protection from infection. In contract, passive immunization studies by various groups have clearly shown that neutralizing antibodies can provide complete protection from infection. A challenge to scientists in the AIDS vaccine development field is now to find ways of generating neutralizing antibodies with the desired epitope specificities at sufficiently high levels through active vaccination using novel immunogens. Last but not least, the topic of innate immunity and its role in leading to adaptive immune responses will also be highlighted.
Scholarship Deadline: November 29 2005
Discounted Abstract Deadline: November 29 2005
Abstract Deadline: December 20 2005
Discounted Registration Deadline: January 27 2006
We gratefully acknowledge additional support for this conference from:
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Merck & Co., Inc.